Simultaneous Parenchyma-Preserving Liver Resection, Cytoreductive Surgery and Intraperitoneal Chemotherapy for Stage IV Colorectal Cancer

References

• Gallagher D. J., Kemeny N. Metastatic colorectal cancer: from improved survival to potential cure. Oncology, 2010, 78: 237–248.
   Google Scholar
• Pawlik T. M., ScoGGiNS C. R., Zorzi D. et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg, 2005, 241: 715–722.
   Google Scholar
• Nordlinger B., sorbye H., Glimelius B. et al. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol, 2013, 14: 1208–1215.
   Google Scholar
• Koppe M. J., Boerman o. C., oyen w. J. G., Bleichrodt R. P. Peritoneal Carcinomatosis of Colorectal Origin. Ann Surg, 2006, 243: 212–222.
   Google Scholar
• Verwaal V. J., Bruin S., Boot H., van Slooten G., van Tinteren H. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol, 2008, 15: 2426–2432.
   Google Scholar
• Carmignani C. P., ortega-Perez G., Sugarbaker P. H. The management of synchronous peritoneal carcinomatosis and hematogenous metastasis from colorectal cancer. Eur J Surg Oncol, 2004, 30: 391–398.
   Google Scholar
• Elias D., Benizri E., Pocard M., Ducreux M., Boige V., Lasser P. Treatment of synchronous peritoneal carcinomatosis and liver metastases from colorectal cancer. Eur J Surg Oncol, 2006, 32: 632–636.
   Google Scholar
• Kianmanesh R., Scaringi S., Sabate J.-M. et al. Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases. Ann Surg, 2007, 245: 597–603.
   Google Scholar
• Chua T. C., Yan T. D., Zhao J., Morris D. L. Peritoneal carcino-matosis and liver metastases from colorectal cancer treated with cytoreductive surgery perioperative intraperitoneal chemotherapy and liver resection. Eur J Surg Oncol, 2009, 35: 1299–1305.
   Google Scholar
• Varban o., Levine E. A., Stewart J. H., McCoy T. P., Shen P. Outcomes associated with cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in colorectal cancer patients with peritoneal surface disease and hepatic metastases. Cancer, 2009, 115: 3427–3436.
   Google Scholar
• Cavaliere F., De Simone M., Virzì S. et al. Prognostic factors and oncologic outcome in 146 patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: Italian multicenter study S.I.T.I.L.O. Eur J Surg Oncol, 2011, 37: 148–154.
   Google Scholar
• Maggiori L., Goéré D., Viana B. et al. Should patients with peritoneal carcinomatosis of colorectal origin with synchronous liver metastases be treated with a curative intent ? A case-control study. Ann Surg, 2013, 258: 116–121.
   Google Scholar
• De Cuba E. M. V., Kwakman R., Knol D. L., Bonjer H. J., Meijer G. A., Te Velde E. A. Cytoreductive surgery and HIPEC for peritoneal metastases combined with curative treatment of colorectal liver metastases: Systematic review of all literature and meta-analysis of observational studies. Cancer Treat Rev, 2013, 39: 321–327.
   Google Scholar
• Carpizo D. R., D’Angelica M. Liver resection for metastatic colorectal cancer in the presence of extrahepatic disease. Lancet Oncol, 2009, 10: 801–809.
   Google Scholar
• Eisenhauer E. A., Therasse P., Bogaerts J. et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer, 2009, 45: 228–247.
   Google Scholar
• Rubbia-Brandt L., Giostra E., Brezault C. et al. Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery. Ann Oncol, 2007, 18: 299–304.
   Google Scholar
• Jacquet P., Sugarbaker P. H. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res, 1996, 82: 359–374.
   Google Scholar
• Clavien P. A., Barkun J., de üliveira M. L. et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg, 2009, 250: 187–96.
   Google Scholar
• Klaver Y. L. B., Simkens L. H. J., Lemmens V. E. P. P. et al. Outcomes of colorectal cancer patients with peritoneal carcino-matosis treated with chemotherapy with and without targeted therapy. Eur J Surg Oncol, 2012, 38: 617–623.
   Google Scholar
• Elias D., Farün M., Goéré D. et al. A simple tumor load-based nomogram for surgery in patients with colorectal liver and peritoneal metastases. Ann Surg Oncol, 2014, 21: 2052–2058.
   Google Scholar
• Esquivel J., Elias D., Baratti D., Kusamura S., Deracü M. Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination. J Surg Oncol, 2008, 98: 263–267.
   Google Scholar
• Egger M. E., Cannon R. M., Metzger T. L. et al. Assessment of chemotherapy response in colorectal liver metastases in patients undergoing hepatic resection and the correlation to pathologic residual viable tumor. J Am Coll Surg, 2013, 216: 845–856.
   Google Scholar
• Ceelen w., Van Nieuwenhüve Y., Putte D. V., Pattyn P. Neoadjuvant chemotherapy with bevacizumab may improve outcome after cytoreduction and hyperthermic intraperitoneal chemoperfusion (hipec) for colorectal carcinomatosis. Annals of Surgical Oncology, 2014, 21: 3023–3028.
   Google Scholar
• Adam R., Pascal G., Castaing D. et al. Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases ? Ann Surg, 2004, 240: 1052–1061.
   Google Scholar